Rankings
▼
Calendar
CLDX Q1 2020 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+91.4% YoY
Gross Profit
-$9M
-328.7% margin
Operating Income
-$13M
-471.7% margin
Net Income
-$13M
-462.8% margin
EPS (Diluted)
$-0.73
QoQ Revenue Growth
+207.6%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$687,000
Balance Sheet
Total Assets
$113M
Total Liabilities
$29M
Stockholders' Equity
$84M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$1M
+91.4%
Gross Profit
-$9M
-$10M
+7.8%
Operating Income
-$13M
-$18M
+28.3%
Net Income
-$13M
-$17M
+26.8%
Revenue Segments
Service
$2M
84%
Grant
$442,000
16%
← FY 2020
All Quarters
Q2 2020 →